Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry

Bone Marrow Transplant. 2018 Jun;53(6):780-783. doi: 10.1038/s41409-018-0096-6. Epub 2018 Jan 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Lymphoma, Follicular / complications*
  • Lymphoma, Follicular / pathology
  • Lymphoma, Follicular / therapy
  • Male
  • Middle Aged
  • Neoplasms, Second Primary
  • Registries
  • Retrospective Studies
  • Rituximab
  • Survival Analysis
  • Transplantation, Autologous / adverse effects*
  • Transplantation, Autologous / methods

Substances

  • Rituximab